How to Use the Zepbound Pen: A Step-by-Step Injection Guide

Key Takeaways

• Zepbound ships as a single-dose auto-injector. Each pen contains one weekly dose. There are no refill cartridges and no dose dial to set.
• The injection takes about 10 seconds. You hear the first click when injection starts and the second click when it finishes.
• Inject into the abdomen (at least 2 inches from the navel), thigh, or upper arm. Rotate sites weekly.
• The pen must be removed from the refrigerator 30 minutes before use to reach room temperature, which reduces injection-site pain.
• After injection, the gray needle guard locks. Discard the entire pen in an FDA-cleared sharps container.

Direct answer (40-60 words)

To use the Zepbound pen, take it out of the fridge 30 minutes before injecting, choose a site (abdomen, thigh, or upper arm), pull off the gray base cap, press the pen flat against the skin, and push down until you hear the first click. Hold for 10 seconds until the second click signals the dose is complete.

Table of contents

1. Before you start
2. Step-by-step injection guide
3. Choosing and rotating injection sites
4. The 10-second hold and why it matters
5. Storage and travel
6. What to do if the pen fails
7. Common pen-use mistakes
8. Side-effect management at the injection site
9. FAQ
10. Sources

Before you start

The Zepbound pen is a single-dose, single-use auto-injector designed for once-weekly injection. Each pen comes pre-filled with one of six available doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg) in 0.5 mL of solution. The pen is engineered for self-injection at home, which means there are no clicks to count, no dose dial to set, and no priming step required.

Before your first injection, gather the following materials:

• The Zepbound pen at room temperature (out of the fridge for at least 30 minutes)
• An alcohol prep pad
• A clean dry tissue or gauze
• An FDA-cleared sharps container

You do not need a needle. The needle is built into the pen and is hidden behind the gray base cap until injection.

Read the manufacturer's Patient Information leaflet (Eli Lilly, Zepbound prescribing information, rev. 2024) at least once before your first injection. Most pen-use errors documented in postmarket pharmacovigilance reports happen because patients didn't read the insert (Heinemann et al., Journal of Diabetes Science and Technology 2023).

Step-by-step injection guide

Step 1: Confirm the pen is correct.

Look at the carton and the pen label. Confirm:

• The medication name says Zepbound
• The dose matches what your provider prescribed (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg)
• The expiration date is in the future
• The liquid in the viewing window is clear or slightly yellow, free of particles

If anything looks off (cloudy liquid, particles, dose mismatch), do not inject. Call the pharmacy.

Step 2: Bring the pen to room temperature.

Take the pen out of the fridge 30 minutes before you plan to inject. Cold injections hurt more, and the cold solution flows more slowly under the skin. Don't warm the pen by running it under hot water, leaving it in sunlight, or microwaving (heat damages tirzepatide).

Step 3: Wash your hands and pick a site.

Wash with soap and warm water, dry. Choose your injection site from these three areas:

• Abdomen, at least 2 inches from the navel
• Front or outer thigh
• Back of the upper arm (someone else may need to do this for you)

Avoid scarred skin, broken skin, tattoos, areas of bruising, areas of redness or inflammation, or hard lumps from previous injections. Wipe the site with an alcohol pad in a circular motion outward, then let it air-dry. Don't blow on it.

Step 4: Pull off the base cap.

Hold the pen at the body (not the top). The gray base cap is on the bottom. Pull it straight off. Do not put the cap back on. The needle is now exposed but will not deploy until you press the pen against your skin.

Step 5: Position the pen.

Hold the pen at a 90-degree angle to your skin (perpendicular). The flat purple base should be in full contact with the skin. You can pinch a small fold of skin if your provider recommends it for thinner sites, but most adults can inject without pinching.

Step 6: Press and listen for the first click.

Push the pen down firmly against the skin. You'll hear a click within 1 to 2 seconds. The first click means the injection has started. Do not lift the pen at this point.

Step 7: Hold for 10 seconds.

Continue pressing the pen against your skin for a full 10 seconds. The window changes from purple to gray during this time, showing the medication is being delivered. You may hear a second click during this period, which signals the dose is complete.

Step 8: Lift the pen.

After 10 seconds, lift the pen straight up off your skin. The gray needle guard locks automatically. The window should now show gray, confirming the dose was delivered.

Step 9: Apply gentle pressure.

If there's a small drop of blood, press a tissue or gauze against the site for a few seconds. Don't rub. Don't apply a bandage unless the site is actively bleeding.

Step 10: Dispose of the pen.

Drop the entire pen into your sharps container. Don't recap. Don't throw the pen in regular trash. Most U.S. pharmacies accept full sharps containers for disposal. The FDA also lists state-specific disposal programs at safeneedledisposal.org.

Choosing and rotating injection sites

The three approved injection sites for Zepbound are the abdomen, the thigh, and the upper arm. The medication is absorbed at roughly the same rate from each site, so the choice is mostly about comfort and access.

Site	Pros	Cons
Abdomen (2 in from navel)	Easiest to see, most fatty tissue, least painful for most patients	Avoid the area around the navel and any waistband line
Front/outer thigh	Easy self-access, good fat layer	Slightly more painful than abdomen for most patients
Back of upper arm	Possible if someone else helps; well-tolerated	Hard to self-inject; small fat layer in lean patients

Rotation matters because injecting the same spot repeatedly causes lipohypertrophy, a thickening of subcutaneous fat that reduces medication absorption (American Diabetes Association Standards of Care, 2024). The fix is simple: pick a new spot each week, at least 1 inch from any previous site.

A common rotation pattern is to divide the abdomen into four quadrants and use a different quadrant each week, then move to the thighs in week 5 and onward.

The 10-second hold and why it matters

The single most-skipped step in auto-injector use is the 10-second hold. In a 2023 user-error survey of GLP-1 patients (Heinemann et al., Journal of Diabetes Science and Technology 2023), 38% of patients lifted the pen before the second click, which leaves a portion of the dose in the device.

Why 10 seconds is the manufacturer specification: the pen uses a spring-driven plunger to push the medication through a fine needle into the subcutaneous tissue. The viscous solution takes time to clear the needle and disperse into tissue. Lifting the pen at 4 or 5 seconds, before the second click, can leave 5 to 15% of the dose either on the skin or in the needle.

If you're not sure whether you held long enough, look at the viewing window. The window must show solid gray (not purple, not partial gray) for a complete dose. If the window still shows purple after you've lifted the pen, contact your pharmacy or provider. Don't inject again to make up the difference.

A useful trick during the hold: count slowly out loud. Most people who count silently rush. Counting out loud anchors you at one second per count.

Storage and travel

Before first use:

• Store in the original carton in the refrigerator at 36 to 46°F.
• Keep upright if possible.
• Do not freeze. If accidentally frozen (even briefly), discard the pen.
• Protect from light by keeping it in the carton.

Room-temperature flexibility:

• The Zepbound pen can be kept at room temperature (up to 86°F) for up to 21 days total. After 21 days at room temperature, discard.
• This is useful for travel and for patients who don't have reliable refrigerator access.

Travel:

• Use an insulated cooler bag with a cold pack for trips longer than 4 to 6 hours.
• Don't pack pens in checked luggage on flights. The cargo hold can fall below freezing. Carry on only.
• TSA explicitly allows injectable medications through security with the prescription label visible.
• If a pen is exposed to temperatures above 86°F, discard. Heat-damaged tirzepatide loses potency unpredictably.

What to do if the pen fails

A small number of pens fail in real-world use. Postmarket data from the FDA Adverse Event Reporting System (FAERS, 2024 cumulative) shows roughly 1 in 1,000 Zepbound pens has a mechanical issue.

If the pen doesn't click: the spring may have failed. Don't try to inject again with the same pen. Call the pharmacy for a replacement. Document the lot number from the carton.

If the medication leaks at the injection site: a small drop is normal. A meaningful leak (more than 0.1 mL pooled on the skin) suggests partial delivery. Don't inject another dose. Call your provider to discuss timing of the next scheduled dose.

If the window doesn't change to gray: the dose was not fully delivered. Don't inject again. Call the pharmacy. Document the lot number.

If the needle is visible after lifting the pen: the safety guard didn't lock. Be careful. Drop the pen carefully into a sharps container without touching the needle. Call the pharmacy to report.

If the pen was exposed to heat or freezing: discard. Don't risk an unpredictable dose.

If you forget your dose:

• If less than 4 days have passed since your scheduled dose, take it as soon as you remember.
• If more than 4 days have passed, skip the missed dose entirely and resume on your next scheduled day.
• Do not take two doses in less than 3 days, ever.

Common pen-use mistakes

Mistake 1: Injecting cold. Cold solution stings. Always wait 30 minutes after pulling the pen from the fridge.

Mistake 2: Lifting the pen at the first click. The first click means injection started. The second click (or the window turning fully gray) means it's done. Hold for the full 10 seconds.

Mistake 3: Injecting near the navel. Stay at least 2 inches away. The skin and underlying tissue near the navel respond unpredictably.

Mistake 4: Using the same site every week. Rotation prevents lipohypertrophy. Move at least 1 inch each week.

Mistake 5: Storing pens in the door of the fridge. The door swings between cold and warm with every opening. Store on a middle shelf.

Mistake 6: Reusing or refilling pens. The Zepbound pen is single-use. There is no refill cartridge. Do not attempt to draw out residual medication for a second dose.

Mistake 7: Confusing the pen with semaglutide pens. Zepbound's auto-injector is different from semaglutide pens. Don't apply technique tips from one pen type to another.

Side-effect management at the injection site

The most common injection-site reactions are mild redness, itching, and small bruises. Published incidence in the SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) showed roughly 6% of tirzepatide patients reported injection-site reactions, almost all mild and self-limited.

Mild redness or itching: apply a cool compress for 10 minutes. Avoid scratching. Most reactions resolve within 24 to 48 hours.

Small bruise: common, especially if a small blood vessel was nicked. Apply gentle cold compress. Resolves in 5 to 7 days.

Hard lump that persists more than a week: could be lipohypertrophy. Stop injecting in that spot. Rotate to a fresh area for at least 8 weeks. The lump will gradually resolve.

Severe reaction (large red welts, blistering, fever): rare but possible. Call your provider same-day. This may indicate hypersensitivity that requires evaluation.

For broader management of GLP-1 side effects beyond the injection site, see our internal guide at /articles/side-effects/glp1-side-effect-management/.

FAQ

Where can I inject Zepbound? The abdomen (at least 2 inches from the navel), front or outer thigh, or the back of the upper arm. The abdomen is the easiest site for self-injection. Rotate sites each week to prevent lipohypertrophy.

Do I need to refrigerate the Zepbound pen? Yes, before first use. Store in the refrigerator at 36 to 46°F. Once removed from refrigeration, the pen can stay at room temperature (up to 86°F) for up to 21 days. After 21 days at room temperature, discard.

How long does the Zepbound injection take? About 10 seconds. You'll hear a first click when injection starts and a second click (or see the window turn fully gray) when the dose is complete. Hold the pen against the skin for the full 10 seconds.

Does the Zepbound pen need priming? No. Unlike multidose pens, Zepbound is a single-dose auto-injector. There is no priming step. Just remove the cap and inject.

Can I reuse a Zepbound pen? No. Each pen is single-use. There's no refill cartridge and no way to dispense a second dose. Discard the entire pen in a sharps container after use.

What size needle is in the Zepbound pen? The pen contains a 29-gauge, 8 mm hidden needle. You don't see or attach a separate needle. The needle deploys when the pen is pressed against your skin and retracts automatically when you lift the pen.

Can someone else give me my Zepbound injection? Yes. A partner or caregiver can inject the back of the upper arm, which is hard to self-inject. The technique is identical: room temperature, alcohol swab, perpendicular pressure, 10-second hold.

How do I know I got the full dose? Look at the viewing window after lifting the pen. The window should be solid gray. Purple or partial gray means the dose may not be fully delivered. If the window doesn't show solid gray, contact your pharmacy.

What if I miss my Zepbound dose? If less than 4 days have passed, take it when you remember. If more than 4 days have passed, skip it and resume on your next scheduled day. Never take two doses within 3 days of each other.

Can I inject Zepbound at any time of day? Yes. Zepbound is once-weekly with no specific time-of-day requirement. Pick a day that's easy to remember and a time that fits your schedule. Some patients prefer evenings to sleep through any mild nausea.

Is the Zepbound pen the same as the Mounjaro pen? The active ingredient (tirzepatide) is the same. The labeling and indication differ. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved for chronic weight management. The auto-injector pens look similar but are not interchangeable. Use only the pen labeled for your prescription.

Does the Zepbound pen hurt? Most patients describe a brief sting or pinch at the moment of injection. The 30-minute room-temperature wait significantly reduces pain. Cold injections hurt more. Site rotation also reduces cumulative discomfort.

Sources

1. Eli Lilly and Company. Zepbound (tirzepatide) Injection: Patient Information and Instructions for Use. Revised 2024.
2. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387:205-216.
3. Heinemann L, et al. User errors with insulin and GLP-1 pen injectors: a 2023 patient survey. Journal of Diabetes Science and Technology. 2023;17(4):951-960.
4. American Diabetes Association. Standards of Medical Care in Diabetes - 2024: Injection technique and lipohypertrophy. Diabetes Care. 2024;47(Suppl 1).
5. U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS). Cumulative Quarterly Data. 2024.
6. Frid AH, et al. New insulin delivery recommendations. Mayo Clinic Proceedings. 2016;91(9):1231-1255.
7. Diabetes Technology Society. 2023 Patient Survey on Injection Device Usability. DTS White Paper.
8. U.S. Food and Drug Administration. Best Way to Get Rid of Used Needles and Other Sharps. safeneedledisposal.org.

Footer disclaimers (all 4 verbatim)

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly. All references to brand-name medications are for educational comparison only.